Histiocytosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis
Condition:   Langerhans Cell Histiocytosis Intervention:   Drug: thalidomide combined with dexamethasone and cyclophosphamide Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)
Condition:   Histiocytosis, Langerhans-Cell Interventions:   Other: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2019 Category: Research Source Type: clinical trials